Schizophrenia

Functional MRI: Applications in Clinical Neurology and Psychiatry

Volumn , Issue , 2006, Pages 181-195

  Callicott, Joseph H ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 55849132305     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (87)

1. DSM-IV. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
2. Goldberg TE, Hyde TM, Kleinman JE, Weinberger DR. Course of schizophrenia: neuropsychological evidence for a static encephalopathy. Schizophr Bull 1993; 19: 797-804.
3. Hoff AL, Sakuma M, Wieneke M, et al. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. Am J Psychiatry 1999; 156: 1336-41.
4. Waddington JL, Scully PJ, Youssef HA. Developmental trajectory and disease progression in schizophrenia: the conundrum, and insights from a 12-year prospective study in the Monaghan 101. Schizophr Res 1997; 23: 107-18.
5. Belitsky R, McGlashan TH. The manifestations of schizophrenia in late life: a dearth of data. Schizophr Bull 1993; 19: 683-5.
6. Geddes J, Freemantle N, Harrison P, Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ 2000; 321: 1371-6.
7. Leucht S, Wahlbeck K, Hamann J, Kissling W. New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and metaanalysis. Lancet 2003; 361: 1581-9.
8. Jeste DV, Palmer BW, Harris MJ. Neuroleptic discontinuation in clinical and research settings: scientific issues and ethical dilemmas. Biol Psychiatry 1999; 46: 1050-9.
9. Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999; 122: 593-624.
10. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44: 660-9.
11. Weinberger DR, McClure RK. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: What is happening in the schizophrenic brain? Arch Gen Psychiatry 2002; 59: 553-8.
12. Kraepelin E. Dementia Praecox and Paraphrenia. Edinburgh: E & S Livingstone, 1919.
13. DeLisi LE, Sakuma M, Tew W, et al. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res 1997; 74: 129-40.
14. Waddington JL, Lane A, Scully PJ, et al. Neurodevelopmental and neuroprogressive processes in schizophrenia. Antithetical or complementary, over a lifetime trajectory of disease? Psychiatr Clin N Am 1998; 21: 123-49.
15. Gottesman II. Schizophrenia Genesis: Origins of Madness. San Francisco: WH Freeman, 1991.
16. Sawa A, Snyder SH. Schizophrenia: diverse approaches to a complex disease. Science 2002; 296: 692-5.
17. Owen MJ, Williams NM, O’Donovan MC. The molecular genetics of schizophrenia: new findings promise new insights. Mol Psychiatry 2004; 9: 14-27.
18. Straub RE, Jiang Y, MacLean CJ, et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002; 71: 337-48.
19. Chumakov I, Blumenfeld M, Guerassimenko O, et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002; 99: 13675-80.
20. Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98: 6917-22.
21. Stefansson H, Sigurdsson E, Steinthorsdottir V, et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71: 877-92.
22. Weiss KM, Terwilliger JD. How many diseases does it take to map a gene with SNPs? Nat Genet 2000; 26: 151-7.
23. Weinberger DR, Egan MF, Bertolino A, et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 2001; 50: 825-44.
24. Callicott JH. An expanded role for functional neuroimaging in schizophrenia. Curr Opin Neurobiol 2003; 13: 256-60.
25. Wright IC, Rabe-Hesketh S, Woodruff PW, et al. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 2000; 157: 16-25.
26. Konick LC, Friedman L. Meta-analysis of thalamic size in schizophrenia. Biol Psychiatry 2001; 49: 28-38.
27. Davidson LL, Heinrichs RW. Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis. Psychiatry Res 2003; 122: 69-87.
28. Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 1999; 45: 17-25.
29. Ingvar DH, Franzen G. Distribution of cerebral activity in chronic schizophrenia. Lancet 1974; 304: 1484-6.
30. Weinberger DR, Berman KF. Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia. Schizophr Bull 1988; 14: 157-68.
31. Berman KF, Zec RF, Weinberger DR. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. Arch Gen Psychiatry 1986; 43: 126-35.
32. Weinberger DR, Berman KF, Zec RF. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 1986; 43: 114-24.
33. Riehemann S, Volz HP, Stutzer P, et al. Hypofrontality in neuroleptic-naive schizophrenic patients during the Wisconsin Card Sorting Test -a fMRI study. Eur Arch Psychiatry Clin Neurosci 2001; 251: 66-71.
34. Weinberger DR, Berman KF. Prefrontal function in schizophrenia: confounds and controversies. Philos Trans R Soc Lond B Biol Sci 1996; 351: 1495-503.
35. Ragland JD, Gur RC, Raz J, et al. Effect of schizophrenia on frontotemporal activity during word encoding and recognition: a PET cerebral blood flow study. Am J Psychiatry 2001; 158: 1114-25.
36. Callicott JH, Ramsey NF, Tallent K, et al. Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology 1998; 18: 186-96.
37. Miller GA. The magical number seven, plus or minus two: some limits on our capacity for processing information. Psychol Rev 1956; 63: 81-97.
38. Cowan N, Chen Z, Rouder JN. Constant capacity in an immediate serial-recall task: a logical sequel to Miller (1956). Psychol Sci 2004; 15: 634-40.
39. Callicott JH, Mattay VS, Bertolino A, et al. Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex 1999; 9: 20-6.
40. Fletcher PC, McKenna PJ, Frith CD, et al. Brain activations in schizophrenia during a graded memory task studied with functional neuroimaging. Arch Gen Psychiatry 1998; 55: 1001-8.
41. Holcomb HH, Lahti AC, Medoff DR, et al. Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task. Am J Psychiatry 2000; 157: 1634-45.
42. Goldberg TE, Berman KF, Mohr E, Weinberger DR. Regional cerebral blood flow and cognitive function in Huntington’s disease and schizophrenia. A comparison of patients matched for performance on a prefrontal-type task. Arch Neurol 1990; 47: 418-22.
43. Curtis VA, Bullmore ET, Brammer MJ, et al. Attenuated frontal activation during a verbal fluency task in patients with schizophrenia. Am J Psychiatry 1998; 155: 1056-63.
44. Curtis VA, Bullmore ET, Morris RG, et al. Attenuated frontal activation in schizophrenia may be task dependent. Schizophr Res 1999; 37: 35-44.
45. Perlstein WM, Carter CS, Noll DC, Cohen JD. Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am J Psychiatry 2001; 158: 1105-13.
46. Jansma JM, Ramsey NF, van der Wee NJ, Kahn RS. Working memory capacity in schizophrenia: a parametric fMRI study. Schizophr Res 2004; 68: 159-71.
47. Volkow ND, Brodie JD, Wolf AP, et al. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration. J Neurol Neurosurg Psychiatry 1986; 49: 1199-202.
48. Andreasen NC, Rezai K, Alliger R, et al. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 1992; 49: 943-58.
49. Cohen BM, Yurgelun-Todd D, English CD, Renshaw PF. Abnormalities of regional distribution of cerebral vasculature in schizophrenia detected by dynamic susceptibility contrast MRI. Am J Psychiatry 1995; 152: 1801-3.
50. Renshaw PF, Yurgelun-Todd DA, Cohen BM. Greater hemodynamic response to photic stimulation in schizophrenic patients: an echo planar MRI study. Am J Psychiatry 1994; 151: 1493-5.
51. Barch DM, Mathews JR, Buckner RL, et al. Hemodynamic responses in visual, motor, and somatosensory cortices in schizophrenia. Neuro-Image 2003; 20: 1884-93.
52. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10: 40-68.
53. Braus DF, Weber-Fahr W, Tost H, et al. Sensory information processing in neuroleptic-naive firstepisode schizophrenic patients: a functional magnetic resonance imaging study. Arch Gen Psychiatry 2002; 59: 696-701.
54. Wible CG, Kubicki M, Yoo SS, et al. A functional magnetic resonance imaging study of auditory mismatch in schizophrenia. Am J Psychiatry 2001; 158: 938-43.
55. Kiehl KA, Liddle PF. An event-related functional magnetic resonance imaging study of an auditory oddball task in schizophrenia. Schizophr Res 2001; 48: 159-71.
56. David AS, Woodruff PW, Howard R, et al. Auditory hallucinations inhibit exogenous activation of auditory association cortex. NeuroReport 1996; 7: 932-6.
57. Dierks T, Linden DE, Jandl M, et al. Activation of Heschl’s gyrus during auditory hallucinations. Neuron 1999; 22: 615-21.
58. Shergill SS, Brammer MJ, Williams SC, et al. Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatry 2000; 57: 1033-8.
59. Shergill SS, Brammer MJ, Amaro E, et al. Temporal course of auditory hallucinations. Br J Psychiatry 2004; 185: 516-7.
60. Surguladze SA, Calvert GA, Brammer MJ, et al. Audio-visual speech perception in schizophrenia: an fMRI study. Psychiatry Res 2001; 106: 1-14.
61. Mattay VS, Callicott JH, Bertolino A, et al. Abnormal functional lateralization of the sensorimotor cortex in patients with schizophrenia. NeuroReport 1997; 8: 2977-84.
62. Kodama S, Fukuzako H, Fukuzako T, et al. Aberrant brain activation following motor skill learning in schizophrenic patients as shown by functional magnetic resonance imaging. Psychol Med 2001; 31: 1079-88.
63. Kumari V, Gray JA, Honey GD, et al. Procedural learning in schizophrenia: a functional magnetic resonance imaging investigation. Schizophr Res 2002; 57: 97-107.
64. Manoach DS, Cain MS, Vangel MG, et al. A failure of sleep-dependent procedural learning in chronic, medicated schizophrenia. Biol Psychiatry 2004; 56: 951-6.
65. Weickert TW, Terrazas A, Bigelow LB, et al. Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input. Learn Mem 2002; 9: 430-42.
66. Jansma JM, Ramsey NF, Slagter HA, Kahn RS. Functional anatomical correlates of controlled and automatic processing. J Cogn Neurosci 2001; 13: 730-43.
67. Jansma JM, Ramsey NF, Kahn RS. Dynamics of working memory in schizophrenia: failure of brain systems to adapt to practise-induced automatization. In: Proceedings of International Conference on Schizophrenia Research; Whistler, British Columbia, 2001: S178-9.
68. Barch DM, Carter CS, Braver TS, et al. Selective deficits in prefrontal cortex function in medicationnaive patients with schizophrenia. Arch Gen Psychiatry 2001; 58: 280-8.
69. Barch DM, Csernansky JG, Conturo T, Snyder AZ. Working and long-term memory deficits in schizophrenia: is there a common prefrontal mechanism? J Abnorm Psychol 2002; 111: 478-94.
70. Perlstein WM, Dixit NK, Carter CS, et al. Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia. Biol Psychiatry 2003; 53: 25-38.
71. Rubia K, Russell T, Bullmore ET, et al. An fMRI study of reduced left prefrontal activation in schizophrenia during normal inhibitory function. Schizophr Res 2001; 52: 47-55.
72. Volz H-P, Nenadic I, Gaser C, et al. Time estimation in schizophrenia: an fMRI study at adjusted levels of difficulty. NeuroReport 2001; 12: 313-16.
73. Honey GD, Bullmore ET, Sharma T. De-coupling of cognitive performance and cerebral functional response during working memory in schizophrenia. Schizophr Res 2002; 53: 45-56.
74. Callicott JH, Bertolino A, Mattay VS, et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 2000; 10: 1078-92.
75. Manoach DS, Gollub RL, Benson ES, et al. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry 2000; 48: 99-109.
76. Quintana J, Wong T, Ortiz-Portillo E, et al. Prefrontal-posterior parietal networks in schizophrenia: primary dysfunctions and secondary compensations. Biol Psychiatry 2003; 53: 12-24.
77. Ramsey NF, Koning HA, Welles P, et al. Excessive recruitment of neural systems subserving logical reasoning in schizophrenia. Brain 2002; 125: 1793-807.
78. Bertolino A, Esposito G, Callicott JH, et al. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am J Psychiatry 2000; 157: 26-33.
79. Johnstone EC, Crow TJ, Frith CD, et al. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976; ii: 924-6.
80. Weinberger DR, DeLisi LE, Neophytides AN, Wyatt RJ. Familial aspects of CT scan abnormalities in chronic schizophrenic patients. Psychiatry Res 1981; 4: 65-71.
81. Reveley AM, Reveley MA, Clifford CA, Murray RM. Cerebral ventricular size in twins discordant for schizophrenia. Lancet 1982; i: 540-1.
82. DeLisi LE, Goldin LR, Hamovit JR, et al. A family study of the association of increased ventricular size in schizophrenia. Arch Gen Psychiatry 1986; 43: 148-53.
83. Callicott JH, Egan MF, Mattay VS, et al. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry 2003; 160: 709-19.
84. Hariri AR, Mattay VS, Tessitore A, et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002; 297: 400-3.
85. Egan MF, Callicott JH, Kojima M, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-69.
86. Egan MF, Straub RE, Goldberg TE, et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci USA 2004; 101: 12604-9.
87. Callicott J, Straub R, Pezawas L, et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci USA 2005; 102: 8627-32.